We have used the Hepatitis B Virus DNA genome as a probe to identify genes clonally mutated in vivo, in human liver cancers. In a tumor, HBV-DNA was found to be integrated into the gene encoding Sarco/Endoplasmic Reticulum Calcium ATPase (SERCA), which pumps calcium, an important intracellular messenger for cell viability and growth, from the cytosol to the endoplasmic reticulum. The HBV X gene promoter cis-activates chimeric HBV X/SERCA1 transcripts, with splicing of SERCA1 exon 11, encoding C-terminally truncated SERCA1 proteins. Two chimeric HBV X/SERCA1 proteins accumulate in the tumor and form dimers. In vitro analyses have demonstrated that these proteins localize to the ER, determine its calcium depletion and induce cell death. We have also shown that these biological eects are related to expression of the SERCA, rather than of the viral moiety. This report involves for the ®rst time the expression of mutated SERCA proteins in vivo in a tumor cell proliferation and in vitro in the control of cell viability.
Introduction
Chronic HBV infection is a major etiologic factor of hepatocellular carcinoma (HCC) (Chang et al., 1997; Hildt et al., 1996) . Although no transforming viral oncogene has so far been identi®ed, HBV-induced chronic liver in¯ammation is thought to play an important role in carcinogenesis (Buendia, 1992; Paterlini and BreÂ chot, 1994) . In addition, the expression of HBV X, PreS2/S (KekuleÂ , 1994) , and PreS1/ PreS2/S (Chisari et al., 1989) viral proteins has been associated with the development of HCC. In particular, the 17 kDa HBV X encoded protein has been shown to activate in trans a wide variety of cellular and viral genes (reviewed in Weil et al., 1999) . HBV X activates signal transduction pathways such as Ras/Raf/MAP kinase (Benn and Schneider, 1994) , Jak1-STAT (Lee and Yun, 1998) and NF-kB signaling (Chirillo et al., 1996) . It has also been suggested that it directly interacts with cellular proteins controlling cell growth (p53 (Truant et al., 1995; Wang et al., 1994a) ), DNA repair (ERCC (Wang et al., 1994b) and UVDDB Sitterlin et al., 1997) ), senescence (Sun et al., 1998) , NFkB activity (Weil et al., 1999) , basal transcription (RBP5 (Cheong et al., 1995) and RMP (Dorjsuren et al., 1998) ), signal transduction (ATF/ CREB (Williams and Andrisani, 1995) ) and with proteasome (Sirma et al., 1998) . Depending on the experimental conditions, HBV X has also been reported to accelerate (Koike et al., 1994) or inhibit cell cycle progression (Benn and Schneider, 1995) , and to induce (Chirillo et al., 1997; Sirma et al., 1999; Terradillos et al., 1998) or inhibit apoptosis (Wang et al., 1995) . Furthermore, HBV X induces HCC in certain transgenic mice (Kim et al., 1991) . However, in a dierent genetic context, HBV X transgenic mice exhibit only increased susceptibility to chemical carcinogenes (Slagle et al., 1996) , or an accelerated development of c-myc induced HCC (Terradillos et al., 1997) .
In addition to these mechanisms, the clonal integration of HBV-DNA into the host cell genome has been found in more than 90% of HBV-related HCCs (Paterlini and BreÂ chot, 1994) . HBV-DNA integration may directly promote genetic instability or lead to cisactivation of growth-related genes (Paterlini and BreÂ chot, 1994) . In certain isolated cases, the viral genome was found to be integrated into the Retinoic acid receptor b gene (Dejean et al., 1986) , and Cyclin A2 gene (Wang et al., 1990) , leading to the expression of chimeric transcripts and proteins, the transforming activity of which was subsequently proved (Berasain et al., 1998; Garcia et al., 1993) . Reports have also been made of HBV-DNA integration in the gene encoding mevalonate kinase in the PLC/PRF/5 cell line (Graef et al., 1994) , and in the Carboxypeptidase N locus in a human HCC (Pineau et al., 1996) . In both instances, chimeric transcripts were identi®ed in the tumor cells, but the eect of their in vitro expression on cell phenotype has not been investigated so far. On the other hand, a number of studies have failed to identify HBV-DNA integration into cellular DNA coding sequences, so that insertional mutagenesis has been considered as a rare event in HBV-related carcinogenesis (Koike, 1998) .
In contrast, in the woodchuck animal model, Woodchuck hepadnavirus (WHV) integration into the N-myc2 and c-myc oncogenes is a frequent event, occurring in more than 70% of tumors, and its transforming eect has been well established (Buendia, 1992) . Interestingly, in some tumors, WHV-DNA integration occurs in a locus called win, which is situated at more than 150 Kb from the N-myc2 gene (Fourel et al., 1994) .
In HBV-related, human HCC, however, the actual impact of insertional mutagenesis has not yet been explored exhaustively. This is due to technical limitations of the genomic libraries previously used for identifying HBV-DNA integration sites, which precluded large scale screening.
Using an original, Alu-PCR-based approach developed in our laboratory (Minami et al., 1995) , we have initiated a screening program of HBV-related HCC, searching for HBV/cellular DNA junctions. In the present study, we report on a liver tumor cell proliferation carrying the HBV-DNA integration into the SERCA1 gene.
SERCA proteins play a pivotal role in regulating cellular calcium (Pozzan et al., 1994) , which, in turn, acts as an intracellular messenger involved in a broad range of specialized and basic cellular activities, ranging from muscle contraction, transmission of neuronal signal, cell proliferation and death (Berridge et al., 1998) . Three distinct SERCA genes encode a number of dierentially expressed isoforms (Wu et al., 1995) . SERCA1a and 1b are mainly found in fasttwitch skeletal muscle, SERCA2a in slow-twitch skeletal and cardiac muscle, SERCA2b is ubiquitous and SERCA3 which also displays isoforms is expressed in several tissues, including hemopoietic, endothelial and secretory epithelial cells. We show here that HBV integration into the SERCA1 gene in a human liver tumor cis-activates SERCA1 chimeric transcripts encoding chimeric proteins. We also provide evidence that the in vitro expression of these transcripts and of their SERCA moiety induces ER calcium depletion and apoptosis. Our study therefore highlights the implication of SERCA1 gene mutation in clonal cell expansion and the control of cell viability.
Results

HBV-DNA integration into the SERCA1 gene drives the expression of chimeric transcripts
By using an HBV X speci®c and an Alu-speci®c primer (Minami et al., 1995) , we have isolated a PCR fragment of 498 bp from a liver tumorous DNA (T86). In this fragment, the HBV X gene was fused in frame with SERCA1 gene exon 3 (67 bp) (Zhang et al., 1995) and intron 3 (247 bp) (MacLennan, personal communication) ( Figure 1A) .
A Northern blot analysis performed on tumorous (T86) and non tumorous mRNAs showed a 3.2 kb transcript, hybridizing with both HBV and SERCA1 probes, and expressed in T86 but not in adjacent, nontumorous liver tissue ( Figure 1B) . A cDNA library, constructed with poly(A) + mRNAs from T86, yielded eight recombinant clones ( Figure 1C ). Their 5' ends showed the same HBV X sequence, starting at nt 1309 HBV (adr4 subtype) (Raney and McLachlan, 1991) , 64 bp before the HBV X ATG, up to nucleotide 1819 (446 in Figure 1A ), fused in frame to SERCA1 cDNA nucleotide 153 in exon 3. Interestingly, SERCA1 cDNA was characterized by the splicing of exon 11, leading to a 22 codon frameshift and a premature stop codon in exon 12. Three of eight clones exhibited an additional splicing of SERCA1 exon 4. These two chimeric cDNAs and encoded proteins will be referred to as Xt/St+4 and Xt/St74: Xt for HBV X truncated sequence fused to truncated SERCA1 (St), with or without exon 4.
Chimeric HBV X/SERCA1 proteins predicted structure prevents calcium pumping According to the cDNA sequence, the chimeric proteins have their SERCA1 N-terminal 51 aminoacids replaced by 148 aminoacids of the HBV X protein and an additional residue encoded by the viral/cellular in frame junction (Figure 2A ). Xt/St+4 protein lacks six putative SERCA1 transmembrane segments (M5-M10), which include ®ve of the six Ca 2+ binding residues (Glu-771, Asn-796, Thr-799, Asp-800, and Glu-908) (MacLennan et al., 1997) as well as the cytoplasmic loop between transmembrane segments 6 and 7 that also controls Ca 2+ binding (Falson et al., 1997) . A mutated peptide of 22 aminoacids is encoded at the Cterminal end. In addition to that, Xt/St-4 protein lacks a peptide (aa. 74 ± 108) encoding the second putative transmembrane segment (M2) and the last ®ve Cterminal residues of M1. The expected size of the Xt/ St+4 and Xt/St74 chimeric proteins is 56 and 53 kDa, respectively.
Thus, although these proteins retain the putative calcium binding residue Glu 309 and the phosphorylatable Asp-351, consistent with previously reported mutants (MacLennan et al., 1998) , they cannot function as calcium pumps.
Chimeric proteins are expressed and form dimers in the tumor
We then looked for these chimeric and truncated proteins in the tumorous tissue (T86) by Western blot. A chimeric protein (53/56 kDa), reacting with both anti-HBV X (anti-X) and anti-SERCA1 antibodies ( Figure 2B ), was clearly detectable in the tumorous tissue. High resolution analysis demonstrated two proteins, of 53 and 56 kDa ( Figure 2C ), which size was consistent with the cDNA sequences. We consistently observed a weaker upper band (56 kDa), as compared to the strongest lower band (53 kDa). This contrasted with the higher number of clones (5/8) encoding the 56 kDa protein. This discrepancy may be due to the non representative number of clones or to dierent conformation and reactivity to the antibody of the two proteins.
Oligomerization of SERCA proteins has been already reported (Martonosi, 1996) . Therefore, in this setting, we looked for heterodimers of endogenous liver SERCA isoform (SERCA2b) and chimeric HBV X/ SERCA1 proteins in the tumorous tissue ( Figure 2C ). Anti-SERCA1 antibody showed absence of heterologous aggregates of SERCA2b with chimeric proteins (predicted size: 163 ± 166 kDa) and, interestingly revealed prominent aggregates of chimeric proteins (106 kDa), possibly corresponding to chimeric dimers, in non-heated tumor sample, whereas SERCA1 in normal fast skeletal muscle (SR) underwent only slight aggregation (220 kDa) under the same conditions. The expression of SERCA2b was sustained in T86 at a level which was not signi®cantly lower than that found in three, dierent, normal livers ( Figure 2D ) and cell lines transfected with the Xt/St constructs (data not shown). SERCA3 mRNA was expressed at very low and similar , HepG 2 cells transfected with HBV (positive control for HBV probe)) was hybridized with SERCA1 and HBV probe, and then normalized with the GAPDH probe. A 3.2 kb transcript hybridizing with both HBV and SERCA1 probe is present in T86 (arrow), but not in NT. In T86 the HBV probe also shows the expression of the 2.1 kb HBV surface transcript. (C) Hybrid cDNAs cloned from T86. Xt/St+4, clones with splicing of SERCA1 exon 11 (-ex11) leading to a frameshift (black box) and a stop codon in exon 12. Xt/St74, clones with exon 11 and exon 4 (-ex4) splicing. X, HBV X sequence levels in both tumorous and corresponding nontumorous tissues (data not shown).
Chimeric SERCA proteins are localized to the ER
We then investigated whether chimeric proteins localize to the ER. According to their predicted structure, they lack 51 (Xt/St+4) or 51+34 (Xt/ St74) N-terminal SERCA1 residues, which include the 28 N-terminal amino acids sequence previously reported as the minimal domain for SERCA proteins retention in the ER (Guerini et al., 1998) . Constructs expressing chimeric proteins, their HBV X and SERCA1 moieties, as well as wild type HBV X and SERCA1 proteins ( Figure 3 ) were cloned in expression vectors with or without fusion to GFP or Myc tag sequences.
The subcellular distribution of the encoded proteins was studied in transiently transfected CCL13 cells, using immuno¯uorescence and scanning confocal microscopy ( Figure We ®rstly tried to analyse the rate of calcium uptake on isolated microsomal fractions. We tested whether we might use transiently transfected cells, sorted by FACS to obtain equivalent amounts of microsomes from cells transfected with dierent constructs. However, we noticed a massive cell death in cells transfected with chimeric cDNAs after sorting, avoiding to perform the test. We then investigated whether chimeric proteins induce, upon in vitro expression, modi®cations of the ER and cytosolic Ca 2+ pools ( Figure 5 ). Indeed, if the SERCA pump activity is reduced, the ER free calcium content will reach a new equilibrium at lower Ca 2+ levels. The cytosolic free [Ca 2+ ] i concentration was studied in cells transiently expressing Xt/St+4-GFP or SERCA1-GFP constructs and in non-transfected cells (NTC). No signi®cant dierence was found in resting cytosolic [Ca 2+ ] i in Xt/St+4 transfected cells (64+4 nM, n=16) when compared to controls (NTC: 61+4 nM, n=18 and SERCA1: 66+5 nM, n=22) (Figure 5b ). In contrast, Xt/St+4 expression decreased the ER The HBV X is depicted as broken line, the peptide created by frameshift is shown as a dotted line and the peptide encoded by exon 4 and deleted in Xt/St74 is in gray. (B) Chimeric protein (X/SERCA) is expressed in T86. The same Western blot (14% SDS ± PAGE) was successively hybridized with anti-HBV X and anti-SERCA1 antibodies. X Ag (21 kDa), puri®ed recombinant HBV X protein (a: 100 ng, b: 50 ng, c: 50 ng mixed with 10 mg of normal liver microsomes); T86, T86 microsomes (50 mg); SR, SERCA1 from rabbit muscle microsomes (50 ng). (C) Western blot (7% SDS ± PAGE) of heated (h) and non-heated (nh) microsomes under mildly denaturing conditions (NL and T86: 50 mg; SR: 20 ng). A band of 106 kDa corresponding to chimeric proteins dimers is present in the T86 non heated sample. (D) SERCA2b protein expression in T86 compared to three normal livers (NL1-3). Western blot analysis was performed on the total protein and normalized with anti-tubulin antibody. The SERCA2b accumulation was not signi®cantly dierent in T86 as compared to normal livers Figure 3 Schematic representation of the dierent cloned constructs. Xt/St+4 and Xt/St74: chimeric clones corresponding to chimeric cDNAs; St+4 and St74, SERCA moieties of chimeric clones; Xt, HBV X moiety; Xtpro, HBV X moiety directed to the ER membrane by means of the prolactin cassette calcium contents to 75 and 80% of the levels found in non-transfected and SERCA1 transfected cells, respectively (Figure 5c ). However, as the whole cell population included 40% of transfected cells (evaluated by GFP expression), the actual level of ER Ca 2+ depletion related to Xt/St+4 expression is expected to be higher. By comparing the results obtained with SERCA1 and SERCA1-GFP, we assessed that fusion to GFP did not per se interfere with ER Ca 2+ contents (data not shown). We therefore concluded that the expression of Xt/St+4 protein leads to a signi®cant reduction in the level of exchangeable Ca 2+ stored in the ER. The high rate of cell death induced by the Xt/St74 construct precluded such analysis and encouraged us to look for apoptosis.
Chimeric SERCA proteins induce apoptosis
Morphological studies were conducted in CCL13 ( Figure 6A ,B) and HuH7 cells (data not shown), by counting the number of apoptotic bodies in GFP expressing cells (see Materials and methods). They demonstrated that both Xt/St+4 and Xt/St74 proteins, as well as their SERCA moieties, St+4 and St74, induce apoptosis to a highly signi®cant degree ( Figure 6B ). FACScan analysis of mitochondrial structure by Nonyl Acridine Orange (NAO) incorporation (Petit et al., 1995) in HepG 2 cells con®rmed these data ( Figure 6C ). The analysis is based on mitochondrial membrane cardiolipins modi®cation, which occurs early during apoptosis and leads to a lower incorpora- Figure 4 Chimeric proteins are localized to ER whereas truncated HBV X moiety (Xt) is mainly nuclear. CCL13 cells transiently transfected with Xt/St+47GFP (green) (a), St+47GFP (green) (c) and with Xt/St747Myc (stained with anti-Myc antibody, green) (b) were immunolabeled with anti-ER antibody (red). Cyto¯uorograms with red in abscissae and green in ordinate, demonstrate colocalization of chimeric proteins and SERCA moiety to the ER. The same cells transfected with Xt/St747GFP (green) (d), Xt/St+47GFP (green) (e) and immunolabeled with anti-mitochondria (red) (d), or anti-Golgi antibodies (red) (e) clearly showed that chimeric proteins do not colocalize to these organelles. Cells transfected with Xt moiety (Xt-GFP, green) and immunolabeled with anti-lamin antibodies (red), which speci®cally label the nuclear membrane, showed that the Xt untargeted moiety is mostly localized into the nucleus (f) Oncogene HBV-related insertional SERCA1 mutagenesis in a HCC M Chami et al tion of NAO. The percentage of apoptotic cells was estimated according to lower NAO incorporation associated to smaller cell size. These results led us to conclude that both chimeric constructs induce apoptosis in three dierent cell lines. In an independent experiment we also tested, by FACS analysis, whether transient transfection of HepG 2 cells with a construct encoding a truncated SERCA protein having a normal N-terminal end and a truncated C-terminal end (SERCA1+4711) was associated to apoptosis. As compared with the empty vector, the SERCA1+4711 construct induced apoptosis at a statistically signi®cant level (22% vs 6%).
Targeting of Xt to the ER abrogates its proapoptotic and transactivating property
By using both morphological counting of apoptotic bodies ( Figure 6B ) and FACScan analysis of mitochondrial membrane by NAO incorporation ( Figure  6C ), we observed that both the wild type (Xwt) and the truncated untargeted HBV X moiety (Xt) induce apoptosis in three dierent cell lines. In contrast with these ®ndings, the ER targeted HBV X moiety (Xtpro) barely induced apoptosis, reaching non signi®cant ( Figure 6B ) or border-line ( Figure 6C ) levels. Thus the proapoptotic eect of chimeric constructs is mainly related to their SERCA moiety. Since the proapoptotic eect of HBV X has been associated to its transactivating property, we analysed the transactivating eect of Xtpro as compared to Xwt and to the Xt moiety. In our system (see Materials and methods), Xwt displayed transactivating activity on NFkB reporter gene . In contrast with these ®ndings, we were not able to evidence a signi®cant transactivating activity of Xtpro and Xt/St+4 in triplicate experiments (Figure 7 ).
Discussion
Our work reports on a new case of cis-activation of a cellular gene upon HBV-DNA integration in a human hepatocellular carcinoma. It also identi®es for the ®rst time SERCA1 as a potential target for mutation in a human cancer.
SERCA2b is the endogenous SERCA in liver tissues, the SERCA1 gene expression being detectable only by RT ± PCR. In the liver tumor we studied, the viral HBV X gene promoter cis-activates two chimeric HBV X/SERCA1 transcripts, characterized by exon 11 splicing and a premature stop codon in exon 12. These transcripts encode chimeric proteins with their C-terminal end truncated and their N-terminal end replaced by the C-terminally truncated HBV X protein. When compared with the functional structure of wild type SERCA1, HBV X/SERCA1 proteins have lost calcium binding residues and the ATP binding domain. They are therefore unable to pump calcium. Further, they have also lost 51 N-terminal residues, including the 28 residues previously identi®ed as the minimal SERCA1 ER targeting signal (Guerini et al., 1998) . Using immuno¯uorescence and confocal analysis, we have shown that these chimeric proteins still localize to the ER, and do not colocalize with mitochondria or Golgi. Since previous reports (Bayle et al., 1997) showed that the ®rst four predicted SERCA transmembrane domains, which are retained in the chimeric protein, act as signal anchor and stop transfer sequences, chimeric proteins are presumed to be inserted into the ER membrane. We cannot, however, rule out misfolding of these proteins into the ER lumen.
With respect to HBV X localization, our results raise two interesting points. Wild type HBV X shows a predominant cytoplasmic localization (Sirma et al., 1998) and it is unclear whether a small fraction translocates or not to the nucleus (Weil et al., 1999) . It has been recently shown that large C-terminal deletions promote HBV X nuclear localization . Although localization signals have not been mapped to date, our study shows that deletion of only ®ve C-terminal residues is sucient to drive HBV X to the nucleus. Moreover, we have shown that, in the chimeric proteins, the HBV X moiety is driven to the ER by the SERCA moiety.
Cells transiently transfected with the chimeric construct display a signi®cant depletion of ER calcium. Several dierent, non-exclusive mechanisms may account for this depletion. Chimeric proteins may downregulate endogenous SERCA2b expression. However, we failed to demonstrate a signi®cantly decreased expression of SERCA2b in the tumorous tissue (T86) as compared to normal livers and in cells transfected with the chimeric constructs. SERCA proteins have been shown to dimerize. Chimeric proteins may form heterodimers or aggregates with endogenous SERCA2b proteins and thus alter their biological activity. However, heterodimers were not detectable by Western blot, even under weak denaturing conditions. Instead, dimers of chimeric proteins were found in the tumorous tissue. HBV X may have favored this dimerization in our model, since in vitro expressed HBV X has indeed been shown to dimerize (Lin and Lo, 1989) . These results suggest that chimeric proteins may determine calcium leakage from the ER by embedding the ER membrane (ER overload) (Pahl and Baeuerle, 1997) or by forming a cation pore upon dimerization of the two M4 transmembrane segments, which contain a calcium binding residue (Rice and MacLennan, 1996) . Finally, calcium release may also follow the accumulation of unfolded proteins in the ER, leading to an unfolded protein response (Kaufman, 1999) . The chimeric SERCA proteins are expected, however, to be inserted into the ER membrane. Overexpression of the SERCA moieties induce apoptosis, while overexpression of the Xtpro construct, which is also inserted into the ER membrane, does not. In agreement with this result, we have also observed that overexpression of the Pro-GFP construct does not induce a decreased ER calcium content (data not shown). Finally, overexpression of truncated SERCA proteins (having the normal SERCA1 N-terminal end, and therefore presumably correctly folded) induce apoptosis in the same proportions as compared with the chimeric SERCA proteins. Therefore, even if we cannot formally rule out a minor contribution of ER overload and/or unfolding protein response to the ER calcium depletion and apoptosis, our data demonstrate that mutated SERCAs are involved in the control of apoptosis.
ER calcium depletion has been shown to cause repression of protein synthesis and folding (Brostrom and Brostrom, 1990 ) which can induce apoptosis (Nicotera and Orrenius, 1998) . SERCA genes, including SERCA1, have consistently been shown to control Inositol 1,4,5-triphosphate (IP3)-mediated calcium waves (Camacho and Lechleiter, 1993; Morgan and Jacob, 1998) and it has been recently shown that calcium wave amplitude and duration dierentially activate certain transcription factors (Dolmetsch et al., 1997) . In this setting, modi®cation of the SERCA function, in the tumor we studied, could have deregulated cell viability and growth. In fact, the transient expression of chimeric proteins induced cell death in three HCC-derived cell lines. In line with previous results from our and other laboratories, we also found that the wild type HBV X protein induces apoptosis. The HBV X moiety, which has lost only ®ve C-terminal residues as compared to the wild type form, also demonstrated a proapoptotic eect, but only in its free form. Namely, apoptotic activity was lost by targeting the HBV X moiety to the ER through a prolactin cassette. As with previously reported data, showing that the proapoptotic eect of HBV X correlates with its transactivation activity, we found that targeting the HBV X moiety to the ER signi®cantly reduced its transactivating property.
Finally, transient transfection of the SERCA moieties massively induced apoptosis. Taken together, these data demonstrate that the SERCA moieties account for most of the apoptotic activity due to Figure 7 Targeting of HBV X moiety (Xt) to the ER decreases its transactivating activity. CCL13 cells were co-transfected with pcDNA3.1 empty vector (pcDNA-3), wild type HBV X (Xwt), Xt/St+4 chimeric construct, and Xtpro (Xt targeted to the ER) expression plasmids and with reporter vector p-NF-kB-LUC and p-b-actin-b-galactosidase (see Materials and methods). A decreased transactivating activity was observed with Xtpro and the chimeric construct Xt/St+4, both targeting the Xt to the ER, as compared to the wild type HBV X protein (Xwt) chimeric proteins. In agreement with our results, Ma et al. (1999) have recently provided evidence for a direct implication of SERCA2a in apoptotic cell death. This is the ®rst report demonstrating that direct mutation of the SERCA1 gene aects the control of cell death. SERCA1 gene mutations have been reported in some patients with Brody disease (MacLennan et al., 1998) characterized by autosomal recessive inheritance of SERCA1 (ATP2A1) gene mutations on chromosome 16p12.1 ± 12.2. In these patients, muscle relaxation is impaired because of the expression of mutated SERCA1 proteins, which are unable to pump calcium. Recently, SERCA2 gene mutations have been reported in Darier-White disease (Sakuntabhai et al., 1999) , a rare dermatosis with dominant inheritance characterized by focal areas of separation between suprabasal epidermal cells, and abnormal keratinocytes dierentiation. Darier-White disease SERCA2 mutations therefore highlight the fact that aberrations of intracellular calcium levels may lead to a distinct program of altered cell growth and dierentiation (Peacocke and Christiano, 1999) .
Our work constitutes the ®rst report on an in vivo SERCA1 gene mutation occurring selectively in tumorous cells and not in adjacent, non tumorous liver tissue. Chromosomal aberrations involving the 16p12 region, which contains the SERCA1 gene, have been detected in several tumors, including pancreatic endocrine tumors, colorectal carcinomas and seminomas (Chung et al., 1998; Ottesen et al., 1997; PircDanoewinata et al., 1996) . Thus, depending on the cellular environment, mutations of SERCA1 might deregulate cell viability and growth.
Our data provide new information concerning the impact of HBV-related insertional mutagenesis. This mechanism has been considered as a rare event in human liver cancer. The number of tumors in which HBV integrants were studied in detail has remained, however, low (around 30 in a 20-year period). We have therefore developed an HBV-Alu PCR based technique to rapidly isolate viral/cellular junctions (Minami et al., 1995) . This approach has allowed us to isolate 18 HBV/cellular DNA junction fragments; among these, new cellular genes have been recently identi®ed (work in progress). Thus, our results suggest that the actual prevalence of HBV-related cis-activation of cellular genes should be reassessed.
In conclusion, our results stimulate further analysis of SERCA gene mutations in cancer, and reinforce the concept that the pharmacological modulation of intracellular calcium may have an impact in cancer treatment (Kohn and Liotta, 1995) .
Materials and methods
Tissues
Tumorous (T86) and non tumorous (NT86) frozen liver tissues were obtained at surgery from a 65-year-old Japanese, HBsAg negative, HBV-DNA positive, anti-HCV positive patient with primary liver cancer. The tumorous tissue was classi®ed as HCC Edmonson's grade 2. Chronic active hepatitis without cirrhosis was found in the non tumorous tissue. Other tumors used for this study were diagnosed as primary liver cancer after pathological examination.
PCR and RT ± PCR protocols and primer sequences DNA was extracted from tumorous and non tumorous tissues as previously described (Paterlini et al., 1990) . In order to amplify HBV/cellular DNA junctions in the tumorous tissue, Alu-PCR was performed as previously reported (Minami et al., 1995) .
RNA isolation and Northern blot analysis
Total cellular RNA was extracted using Trizol reagent (Life Technologies). mRNA isolation was done using Dynabeads oligo (dT) (Dynal). Northern blot was performed as described (Church and Gilbert, 1984) . Full-length SERCA1 cDNA and full-length HBV cDNA were used as speci®c probes. Blots were normalized with a full-length GAPDH cDNA probe.
cDNA cloning Double strand cDNA was synthesized using the Marathon TM cDNA Ampli®cation kit (Clontech) starting from 1 mg of poly(A) + RNA from T86. The cDNA 5' and 3' ends were ampli®ed and sequenced with adaptor primer AP1 (Marathon kit) and HBV-junction primers Hsh-s (5'-accagcaccatgcaagctggtgatagagca-3' and Hsh-r (5'-accagcaccatgcaagctggtgatagagca-3'). Full-length hybrid cDNAs were ampli®ed with HBV X-s (5'-tttccatggctgctaggctgtactgccaa-3') and SERCA1 ex23-r (5'-cacagctctgcctgaagatgtgtcact-3') primers and cloned into pMos vector (Gibco ± BRL).
Isolation of microsomal fraction and immunoblotting
Liver microsomes were isolated as described (Heilmann et al., 1985) . Proteins were treated with concentrated urea (20 mg/ 50 mg protein), SDS 1.8% and b-mercaptoethanol 9%. After SDS ± PAGE (14%), proteins were electrotransferred onto PVDF membranes (Immobilon). For immunodetection, we used rabbit polyclonal antibody raised against HBV X protein (gift from P Arbuthnot), guinea-pig polyclonal antibody 79 B raised against rabbit fast twitch muscle SERCA1 (gift from AM LompreÂ ), mouse monoclonal antibody raised against human SERCA2 (anti-SERCA2, clone IID8, Tebu) and mouse monoclonal antibody raised against human b-tubulin (Boehringer Mannheim). Following reaction with a horseradish peroxydase-coupled secondary antibody (goat anti rabbit or anti-guinea-pig or anti-mouse), immunodetection was visualized by the super signal kit (Pierce). Dimers or aggregates were sought with 7% SDS ± PAGE in non-heated samples under mildly denaturing conditions (without urea) (SoulieÂ et al., 1996) .
Plasmid constructs and transient transfection
The constructs shown in Figure 3 were subcloned into pcDNA3.1, pcDNA3.1/Myc-His (Invitrogen) and pEGFP-N1 (Clontech) and were used to transfect hepatoma derived cell lines (CCL13, HuH7 and HepG 2 ) by the calcium phosphate coprecipitation method (10 mg/dish). The Xtpro construct was obtained by subcloning Xt downstream the ER membrane targeting cassette (prolactin peptide signal, b lactamase sequence and IgM stop transfer signal, gift of V Lingappa). In addition to that, we also cloned the prolactin cassette upstream to the GFP sequence (ProGFP) and the SERCA1+4711 constructs.
Immunofluorescence
Cells were ®xed in 4% paraformaldehyde and permeabilized for 30 s in acetone/methanol (1 : 1). Non-speci®c binding sites were blocked with 3% bovine serum albumin. Immunostaining was performed with anti-ER polyclonal antibody (gift from D Louvard), anti-myc monoclonal antibody (9E10, Santa Cruz), anti-mitochondria polyclonal antibody (gift from C Marsac), anti-Golgi monoclonal antibody (gift from M Bornens), and anti-lamin B antibody. Immunodetection was carried out using a¯uorescein isothiocyanate (FITC) (green), texas red or Cy5 (red)-conjugated second antibody. Coverslips were analysed using confocal laser scanning microscopy (Zeiss, LSM 510).
Cell calcium contents
CCL13 cells were loaded with the¯uorescent Ca 2+ indicator fura2-AM (1.2 mM) for 40 min at 378C in loading buer that does not contain Ca
2+
. Successive applications of EGTA (0.1 mM), 2,5-Di-tert-butylhydroquinone (TBUBHQ, 50 mM), speci®cally inhibiting SERCA and thus releasing the ER calcium, and of ionomycin (IONO, 2 mM), which is a nonspeci®c calcium ionophore, enabled us to determine the increase in [Ca 2+ ] i due to the ER and non-ER Ca 2+ pools, respectively (Figure 5a ). The cytosolic-free Ca 2+ concentration ([Ca 2+ ] i ) was determined by the ratio of 340/380 nm uorescence intensities using a K d for Ca 2+ -dye of 225 nM, and the maximum and minimum¯uorescence responses were determined as described (Grynkiewicz et al., 1985) .
Apoptosis
Transfected cells were analysed 48 h after transfection with GFP-fusion constructs. The percentage of apoptotic nuclei was evaluated in GFP-positive cells using the DNA-dye 7-amino actinomycin D (7-AAD). Alterations to mitochondrial structure were assessed following Nonyl Acridine Orange (NAO) incorporation (Petit et al., 1995) . Adherent and oating cells were incubated for 30 min at 378C in PBS containing 4 mM NAO and harvested cells were then analysed in the FACScan¯ow cytometer. Data from 20 000 events were recorded on a logarithmic scale and analysed using cell Quest software.
Transactivation assay
CCL13 cells were cotransfected with 2 mg of each of reporter vectors: p-NF-kB-LUC, (containing the luciferase gene under the control of the NF-kB promoter) and p-b-actin-bgalactosidase (b-galactosidase gene under control of b-actin promoter) and 5 mg of the dierent activators (wild type X, Xtpro, Xt/St+4 and the empty expression plasmid pcDNA3). Luciferase and b galactosidase analyses were performed according to standard protocols . Luciferase activity was normalized against b galactosidase activity. Data presented are the mean values of transfections done in triplicate experiments.
